Colombian govt to buy Cuban vaccines
The Colombian government plans to once again buy Cuban-made vaccines and is looking into producing Cuban pharmaceuticals, according to a report on the Granma web site. During a visit to that island nation, Colombian Minister of Social Protection Diego Palacio Betancourt told the Cuba-based news service that Colombia is looking to obtain any product necessary for public health that is high quality and has a good price.
The Minister called for a strengthening of bilateral relations relating to health care through projects in Colombia, at first on a regional scale, using the best Cuban technologies effective in the early detection of congenital malformations in the prenatal stage, HIV, prostate cancer, and hepatitis B, Granma daily reported. For 10 years, from 1992-2002, Colombia bought Cuban-made vaccines.
This article is accessible to registered users, to continue reading please register for free. A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.
Login to your accountTry before you buy
Free
7 day trial access
- All the news that moves the needle in pharma and biotech
- Exclusive features, podcasts, interviews, data analyses and commentary from our global network of life sciences reporters.
- Receive The Pharma Letter daily news bulletin, free forever.
Become a subscriber
£820
Or £77 per month
- Unfettered access to industry-leading news, commentary and analysis in pharma and biotech.
- Updates from clinical trials, conferences, M&A, licensing, financing, regulation, patents & legal, executive appointments, commercial strategy and financial results.
- Daily roundup of key events in pharma and biotech.
- Monthly in-depth briefings on Boardroom appointments and M&A news.
- Choose from a cost-effective annual package or a flexible monthly subscription
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed
Chairman, Sanofi Aventis UK
Today's issue
Company Spotlight
Copyright © The Pharma Letter 2024 | Headless Content Management with Blaze